周四盘中，Collegium Pharmaceutical, Inc.（股票代码：COLL）股价大涨5.82%，引起投资者广泛关注。这一显著涨幅与公司最新发布的强劲财报密切相关。
根据公司公告，Collegium Pharmaceutical第二季度营收达到1.88亿美元，超过了IBES分析师预期的1.809亿美元。这一业绩表现优于市场预期，显示出公司在当前经营环境下保持了良好的增长势头。
除了亮眼的季度业绩外，Collegium Pharmaceutical还发布了令人鼓舞的全年业绩指引。公司预计全年调整后EBITDA将达到4.4-4.55亿美元，全年营收预期为7.45-7.6亿美元。这一积极的前景展望进一步增强了投资者对公司未来增长潜力的信心，推动股价大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.